Insider Stock Trading History of Clement Christopher G


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Clement Christopher G since year 2005. The trader's CIK number is 1218808. At the time of this reporting, Clement Christopher G is the President & CEO of Point Therapeutics Inc . (stock ticker symbol POTP). See this page for all insider trading activities at Point Therapeutics Inc .

Note that in the past CLEMENT CHRISTOPHER G also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Clement Christopher G since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-06-03 DARA Point Therapeutics Inc Buy 14,000 .71 9,982
2009-12-09 SVNT Savient Pharmaceuticals Inc Sale 200 4.81 961
2008-12-09 SVNT Savient Pharmaceuticals Inc Sale 9,225 4.79 44,187
2008-04-14 SVNT Savient Pharmaceuticals Inc Sale 7,570 19.06 144,299
2008-02-15 SVNT Savient Pharmaceuticals Inc Sale 11,112 20.00 222,240
2008-01-17 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.97 14,850
2008-01-15 SVNT Savient Pharmaceuticals Inc Sale 5,000 21.36 106,795
2008-01-16 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.97 14,850
2008-01-15 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.88 14,375
2008-01-17 SVNT Savient Pharmaceuticals Inc Sale 5,000 20.29 101,450
2008-01-16 SVNT Savient Pharmaceuticals Inc Sale 5,000 21.24 106,199
2008-01-10 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.78 13,899
2008-01-11 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.78 13,899
2008-01-10 SVNT Savient Pharmaceuticals Inc Sale 5,000 22.42 112,100
2008-01-11 SVNT Savient Pharmaceuticals Inc Sale 5,000 22.00 109,995
2008-01-14 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.78 13,899
2008-01-14 SVNT Savient Pharmaceuticals Inc Sale 5,000 21.64 108,200
2008-01-08 SVNT Savient Pharmaceuticals Inc Option Ex 2,000 2.78 5,560
2008-01-07 SVNT Savient Pharmaceuticals Inc Sale 5,000 23.00 115,000
2008-01-09 SVNT Savient Pharmaceuticals Inc Option Ex 5,000 2.78 13,899
2008-01-08 SVNT Savient Pharmaceuticals Inc Sale 5,170 23.15 119,690
2008-01-09 SVNT Savient Pharmaceuticals Inc Sale 5,000 21.88 109,410
2008-01-03 SVNT Savient Pharmaceuticals Inc Sale 5,000 24.23 121,160
2008-01-02 SVNT Savient Pharmaceuticals Inc Sale 5,000 23.95 119,760
2007-12-10 SVNT Savient Pharmaceuticals Inc Sale 11,229 15.26 171,354
2007-04-12 SVNT Savient Pharmaceuticals Inc Sale 7,608 12.00 91,296
2007-03-05 SVNT Savient Pharmaceuticals Inc Sale 34,231 12.59 430,968
2007-02-15 SVNT Savient Pharmaceuticals Inc Sale 7,624 14.49 110,441
2006-04-12 SVNT Savient Pharmaceuticals Inc Sale 10,313 5.87 60,537
2005-05-18 SVNT Savient Pharmaceuticals Inc Buy 15,000 3.09 46,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clement Christopher G (President & CEO of Point Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.